• Since the School of Pharmacy’s inception in 2016, it has graduated 261 pharmacists, many of whom are now shaping healthcare delivery across the country.

Kabarak University, under the leadership of Professor Henry Kiplangat, has once again affirmed its position as a trailblazer in health sciences education and research, hosting the 15th International Research Conference with a sharp focus on cancer care and pharmaceutical innovation.

With characteristic poise and conviction, the Vice Chancellor of Kabarak University, officially opened the 15th International Research Conference on September 18, 2025 hosted by the School of Pharmacy—an event that not only spotlighted cancer care innovation but also underscored the fruits of his visionary leadership.

The two-day event, led by the School of Pharmacy in collaboration with the International Cancer Institute, convened experts, students, and industry leaders under the theme “Advancing Access to Quality Cancer Care and Control.”

Addressing a packed auditorium of scholars, practitioners, and students, Professor Kiplangat declared, “This conference is a testament to what diligent stewardship, strategic partnerships, and a commitment to excellence can achieve.”

Read More

  1. Born into Care: Why Patient Safety Must Begin at Birth
  2. Gen-Zs Will Not Vote in 2027, Says Political Analyst
  3. What You Need to Know About the UN’s 80th Anniversary Summit
Kabarak University Vice Chancellor Prof Henry Kiplangat. (Photo/Courtesy)

Under his leadership, Kabarak University has evolved from a promising institution into a national beacon of academic rigour and ethical leadership.

The conference was held in collaboration with the International Cancer Institute and focused on Kenya’s growing cancer burden—over 44,000 new cases and nearly 30,000 deaths in 2022 alone. In response, Professor Kiplangat unveiled two groundbreaking programs:

  • Master of Pharmacy in Oncology Pharmacy: The first of its kind in Kenya, designed to produce practice-ready oncology pharmacists equipped to serve both local and global healthcare systems.
  • Master of Pharmacy in Pharmaceutical Manufacturing: Launching in January 2026, this program aims to reduce Kenya’s reliance on imported medicines and expatriate expertise by cultivating homegrown talent.

“These programs are not just academic offerings,” the VC emphasized. “They are strategic interventions—designed to meet national needs and elevate Kenya’s standing in global pharmaceutical innovation.”

Since the School of Pharmacy’s inception in 2016, it has graduated 261 pharmacists, many of whom are now shaping healthcare delivery across the country.

Professor Kiplangat credited this success to Kabarak’s unwavering commitment to Biblical Christian values, academic excellence, and industry-aligned training.

Kabarak University: A Legacy of Leadership

Under Professor Kiplangat’s stewardship, Kabarak University has:

  • Secured full accreditation from the Pharmacy and Poisons Board and the Commission for University Education.
  • Forged strategic partnerships with global institutions like the International Cancer Institute.
  • Pioneered programs that respond directly to Kenya’s healthcare and manufacturing gaps.
  • Cultivated a culture of integrity, compassion, and innovation across all faculties.

As the conference continues, one thing is clear: Kabarak University’s ascent is no accident. It is the result of deliberate, values-driven leadership.

Stay connected with us on WhatsApp and X for instant updates and breaking news as it happens.